CONTACT
+91 80 2808 2808
info@biocon.com
Biocon  /  Businesses  /  Biosimilars  /  Matthew Erick

Matthew Erick

Chief Commercial Officer - Advanced Markets

Matthew Edward Erick

Matthew Erick

Chief Commercial Officer – Advanced Markets

Matthew Erick is the Chief Commercial Officer – Advanced Markets and is based in the US. Matt joined Biocon in 2022 and is responsible for driving the commercial strategy and sales for Biocon Biologics in the advanced markets of North America, Europe, Japan, Australia and New Zealand.

As we look to expand our global commercial footprint and integrate the recently acquired Viatris commercial infrastructure and capabilities in advanced markets, Matt will take a lead role in both building and implementing our ‘Go to Market’ strategy in advanced markets.

Matt joins us with over two decades of rich experience in pharma and healthcare and has held various commercial and executive leadership roles at MedVet, Viatris, Cardinal Health in the US.

He has a demonstrated track record of strategic planning, successfully driving business growth and profitability, leading commercial operations, managing large teams and developing a collaborative work culture.

Matthew holds Bachelor’s degrees in both Pharmacy and Biology.

Share
Previous Next
Close
Test Caption
Test Description goes like this